Ultrasound Plus Nerve Stimulator Versus Nerve Stimulator Guided Lumbar Plexus Block
A Randomized Comparison of Ultrasound Plus Nerve Stimulator Guided Lumbar Plexus Block to Conventional Nerve Stimulator Guided Technique Using Winnie Approach
1 other identifier
interventional
48
1 country
1
Brief Summary
Ultrasound imaging, an effective tool to localize peripheral nerves, may facilitate block performance. It allows direct visualization of nerve structures, needle guidance in real-time to the target, and observation of local anesthetic diffusion. Some case series have demonstrated significantly faster onset time for interscalene blocks, supraclavicular blocks and axillary brachial plexus blocks under ultrasound than with conventional techniques. Ultrasound guidance also enhances the quality of popliteal sciatic nerve block at the popliteal fossa compared with single injection, nerve stimulator-guided block using either a tibial or peroneal endpoint. Despite this impressive profile, the application of the ultrasound for lumbar plexus blocks has not been studied extensively. It is likely that lumbar plexus block (LPB) combined with either a sciatic nerve block or sedation or both is equivalent to general anesthesia and neuraxial anesthesia for knee arthroscopy. The lumbar plexus block is traditionally performed using surface anatomical landmarks and nerve stimulation. Ultrasound imaging of the anatomy relevant for LPB is challenging because of its deep anatomic location and the "acoustic shadow" of the overlying transverse processes. Recently, Karmakar M.K. etc. has demonstrated that a paramedian transverse scan (PMTS) of the lumbar paravertebral region with the ultrasound beam being insonated through the intertransverse space (ITS) and directed medially toward the intervertebral foramen (PMTS-ITS) may overcome the problem of the "acoustic shadow" and allow clear visualization of the anatomy relevant for LPB. However, the application of a PMTS-ITS used for lumbar plexus blocks has not been studied extensively and its advantages are not validated in a clinical study. Thus, we designed this prospective, randomized, subject and assessor blinded, parallel-group, active-controlled study to compare a PMTS ultrasound-guided lumbar plexus block combined with nerve stimulation and a conventional technique on time required to readiness for surgery in patients undergo knee arthroscopy surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 28, 2013
CompletedFirst Posted
Study publicly available on registry
December 24, 2013
CompletedStudy Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedNovember 14, 2019
November 1, 2019
7 months
November 28, 2013
November 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Onset time of sensory block to cold and pinprick
Onset time of sensory block (cold/pinprick), defined as time interval from completion of local anesthetic injection to the achievement of complete sensory block (defined as no sensation in three major branches including the femoral nerve, the lateral femoral cutaneous nerve and the obturator nerve) .
up to 40 min after ropivacaine injection
Secondary Outcomes (8)
Total ultrasound visibility score (UVS)
30 min before and 5 min after lumbar plexus block
Performance time of block
up to 20 min after needle insertion
Number of needle passes during block
up to 20min after needle insertion
Minimal stimulating current of the needle
up to 20min after needle insertion
Onset time of motor block
up to 40min after ropivacaine injection
- +3 more secondary outcomes
Study Arms (2)
U+N group
EXPERIMENTALUltrasound and nerve stimulator guided lumbar plexus block combined with nerve stimulator guided sciatic block
N group
ACTIVE COMPARATORNerve stimulator guided lumbar plexus block combined with nerve stimulator guided sciatic nerve block
Interventions
An insulated nerve block needle connected to a nerve stimulator that was delivering a current of 1.5 mA at a frequency of 2 Hz was then inserted in the long axis (in- plane) of the ultrasound transducer towards the the hypoechoic psoas compartment. If the quadriceps contraction which produces patella twitching was elicited with an initial current of 1.5mA,then the current should be reduced until contraction is still present between 0.3 to 0.5 mA .Afterward, the lumbar plexus nerve block was performed by using 30mL of 0.5% ropivacaine. Contraction should stop below a current of 0.3mA, otherwise intraneural needle position should be suspected.
The block was conducted following traditional Winnie approach. The accepted end point for the lumbar plexus is stimulation of the femoral nerve component, observed by contraction of the quadriceps muscle. Quadriceps contraction which produces patella twitching should be sought with an initial current of 1.5mA, and once elicited the current should be reduced until contraction is still present between 0.3 to 0.5 mA. Afterward, the lumbar plexus nerve block was performed by using 30mL of 0.5% ropivacaine. Contraction should stop below a current of 0.3mA, otherwise intraneural needle position should be suspected.
Eligibility Criteria
You may qualify if:
- Informed consent
- Age 18-70yr
- American Society of Anesthesiologists physical status I-II
- Patients scheduled to undergo knee arthroscopy surgery
- Ultrasound visibility score equal or great than 10
You may not qualify if:
- Body mass index more than 35 kg/m²
- Pregnant or lactating women
- Allergy to local anesthetics
- Coagulopathy, on anticoagulants
- Malignancy or infection at puncture site
- Significant peripheral neuropathy or diabetic peripheral neuropathy
- Language barrier
- Neuropsychiatric disorder
- Severe cardiac or respiratory diseases
- Pathology or previous surgery or trauma to the lower limb
- Analgesics intake, history of substance abuse
- History of spinal surgery or deformity
- Ultrasound visibility score less than 10
- Participating in the investigation of another experimental agent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tongji Hospital
Wuhan, Hubei, 430030, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wei Mei, MD., PhD.
Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- STUDY CHAIR
Yuke Tian, MD., PhD.
Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 28, 2013
First Posted
December 24, 2013
Study Start
January 1, 2014
Primary Completion
August 1, 2014
Study Completion
October 1, 2014
Last Updated
November 14, 2019
Record last verified: 2019-11